Gene · 5270
Papers2,089
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 2,089
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Multi-Omics Identification of Biomarkers for High-Altitude Pulmonary Hypertension. | J Cardiovasc Dev Dis | 2026 | 42188081 | PubTator, text mining | PubMed |
| Temperature-dependent ligand relocation reveals plasticity of TRPM4 inhibition. | bioRxiv | 2026 | 42182356 | PubTator, text mining | PubMed |
| Clinical Translatable and Transparency of Neural Network for Blood-Based Personalized Cancer Risk. | Mayo Clin Proc Digit Health | 2026 | 42170495 | PubTator, text mining | PubMed |
| Short-term vaginal prasterone therapy induces steroid receptor modulation and extracellular matrix remodeling in human vaginal mucosa. | Sci Rep | 2026 | 42156451 | PubTator, text mining | PubMed |
| Multi-omics insights into SERPINE2-driven post-metastatic microenvironmental reprogramming in advanced cancers: implications for molecular targeting and immunotherapy. | Front Immunol | 2026 | 42099617 | PubTator, text mining | PubMed |
| Multi-Modal Analysis of Programmed Cell Death Identifies Biomarkers and Informs Prognosis in Osteosarcoma. | Int J Mol Sci | 2026 | 42074075 | PubTator, text mining | PubMed |
| Combined Circulating microRNA and Inflammatory Cytokine Profiles Improve Disease-Stage Discrimination of Charcot Foot in Egyptian Patients with Type 2 Diabetes Mellitus. | Biomedicines | 2026 | 42072291 | PubTator, text mining | PubMed |
| Human iPSC-derived macrophages for studying intrinsic and extrinsic factors in cystic fibrosis. | EXO | 2026 | 42039762 | PubTator, text mining | PubMed |
| A computational framework identifies a matrisome-related gene signature for bladder cancer prognosis and prioritizes candidate compounds. | Comput Biol Chem | 2026 | 42030617 | PubTator, text mining | PubMed |
| KAT2A Promotes the Progression of Renal Cell Carcinoma by Regulating the Succinylation of SERPINE2. | Kaohsiung J Med Sci | 2026 | 41968399 | PubTator, text mining | PubMed |
| Prediction model for frailty risk in ischemic stroke patients: Application and validation of support vector machines and nomograms. | Medicine (Baltimore) | 2026 | 41931357 | PubTator, text mining | PubMed |
| Combined Model of Inflammatory-Nutritional Indicators and Tumor Markers for Predicting Prognosis in Patients with Distal Cholangiocarcinoma: A Retrospective Cohort Study. | Diseases | 2026 | 41891998 | PubTator, text mining | PubMed |
| Correction: Single-cell RNA-seq integrated with multi-omics reveals SERPINE2 as a target for metastasis in advanced renal cell carcinoma. | Cell Death Dis | 2026 | 41876448 | PubTator, text mining | PubMed |
| Perineural spread of colorectal carcinoma into the sciatic nerve with positive circulating tumor DNA test: illustrative case. | J Neurosurg Case Lessons | 2026 | 41871390 | PubTator, text mining | PubMed |
| Proteomic profiling of CD133 + and CD326 + (EpCAM) subpopulations in A549 cells: insights into pluripotency and tumor heterogeneity. | Clin Transl Oncol | 2026 | 41870841 | PubTator, text mining | PubMed |
| Deguelin inhibits perineural invasion in esophageal squamous cell carcinoma via targeting BDNF/TrkB axis. | Cancer Biol Ther | 2026 | 41851958 | PubTator, text mining | PubMed |
| Construction and validation of an osteosarcoma prognostic model reveals that SERPINE2 contributes to the progression and cisplatin sensitivity in osteosarcoma. | Int J Biol Macromol | 2026 | 41825672 | PubTator, text mining | PubMed |
| Perineural invasion in digestive tract tumors: Immune system interactions and therapeutic strategies. | World J Clin Oncol | 2026 | 41810344 | PubTator, text mining | PubMed |
| Neuro-immune-related gene signatures define molecular subtypes and prognostic score in bladder cancer with SERPINE2 as a potential therapeutic target. | PeerJ | 2026 | 41800135 | PubTator, text mining | PubMed |
| OralDB: A Transcriptomic Resource for Mechanistic Exploration in Oral Diseases. | J Dent Res | 2026 | 41796996 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5270/papers?page=2